Sabra Health Care REIT, Inc. (NASDAQ:SBRA) is presently under the radar of eleven ratings firms, as Bloomberg reports. To date, two investment analysts have given it a sell recommendation, six consider holding on to it a wiser decision and one has given it a buy recommendation. Moreover, the company’s average 12-month price target, issued by brokers who have bestowed ratings upon the stock during the last year, is $12.72.
As of March 31st, 2023, Sabra Health Care REIT’s portfolio count included an impressive 396 real estate properties held for investment purposes comprising of 258 Skilled Nursing/Transitional Care facilities, 47 senior housing communities (Senior Housing – Leased), 59 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), 17 Behavioral Health facilities and finally, 15 Specialty Hospitals along with other miscellaneous facilities.
The most recent business injunction disclosed its quarterly dividend paid on May 31st to all stakeholders recorded on May 16th. These shareholders were issued a $0.30 per share dividend which when annualized stands at $1.20 accompanied by an enticing yield of10.20%. All those who divested their shares preceding May15th could not benefit from this high-yielding opportunity as that was the ex-dividend date announced prior to quarter-end earnings release.
Despite negative payout ratio being recorded standing currently at -214.28%, Sabra always remained operational in a profit-making manner barring some infrequent mishaps reported over time but that happens every so often maintaining corporate compliance standards while complying with commercial prerequisites aimed at bolstering shareholder value-driven activities and delivering customer satisfaction beyond expectations across all spectrums boosting their long-term growth prospects ultimately leading to career growth opportunities paving their way towards securing higher returns for them guaranteed through these strategic investments that uphold ethical work practices.
In conclusion, Sabra has massive liquidity as reported in last year’s earnings. It is a company that believes in preserving cash and distributing profits through dividends to its shareholders gradually facilitating the growth of the business strategy. With high confidence ratings and an impressive portfolio count of well-diversified real estate properties, Sabra seems like a viable investment option for those looking forward to investing in this sector.
[bs_slider_forecast ticker=”SBRA”]
Mixed Opinions from Analysts and Hedge Funds on Sabra Health Care REIT
Sabra Health Care REIT has been the talk of numerous analysts as of late, with various rating agencies weighing in on the company’s performance and stock value. Wells Fargo & Company initiated coverage on Sabra Health Care REIT citing an “underweight” rating with a $11.00 price objective back on April 19th. Following suit, Credit Suisse Group reissued a “neutral” rating with a $13.00 price target for Sabra Health Care REIT on April 12th. Truist Financial downgraded their rating from “buy” to hold and decreased their price objective from $14.00 to $13.00 in late March, while Stifel Nicolaus also reduced their price target from $15.00 to $14.00 during early May.
Despite these mixed opinions from analysts, Sabra Health Care REIT’s stock opened at $11.76 on Tuesday with a market capitalization of $2.72 billion and a beta of 1.30. The company holds a PE ratio of -21.00, which is often characterized by negative earnings and signals potential future growth over time.
Additionally, Sabra Health Care REIT has seen considerable investor attention lately with various hedge funds buying and selling shares of the company over the last few months alone. Ziegler Capital Management LLC purchased a new stake in Sabra valued at around $1,066,000 in Q4 2020, while Retirement Systems of Alabama increased its holdings by 0.7% during the same quarter before acquiring an additional 2,054 shares during the period.
Furthermore, Versor Investments LP bought into Sabra Health Care REIT’s position for roughly $938,000 last Q4 – while Mirae Asset Global Investments Co Ltd saw enormous gains after increasing their stake by 467%, subsequently claiming ownership of around 637K shares worth approximately $7,922M.
Lastly, Arizona State Retirement System increased its shares in Sabra Health Care REIT’s position by 3.8% last quarter when they purchased an additional 2K+ shares. All of these purchases combined dramatically demonstrate that hedge funds & institutional investors own majority control over the stock at roughly 87.20%, which can create challenges for smaller stakeholder participation.
In conclusion, Sabra Health Care REIT has had an up-and-down history with a wide range of opinions and recommendations from rating agencies and analyst reports lately, leaving investors perplexed about what to do in the coming months. However, despite that, hedge funds have still been enthusiastic about purchasing or selling shares – which could indicate future potential growth for the company.